Inspections and Audits

Kolmar Korea Cited for Slew of Violations

The FDA hit Kolmar Korea with a Form 483 over numerous violations — including negligent handling of documents, lack of employee training and failure to conduct process validation — after a September inspection of its Sejong City, South Korea facility. Read More